INFORMATION SCIENCES CONSULTING, INCORPORATED - REVISED LCATS TO MEET GOVERNMENT NEEDS
Key Details
Description
REVISED LCATS TO MEET GOVERNMENT NEEDS
Context & Analysis
Department of Veterans Affairs obligated $3,224,213.57 to INFORMATION SCIENCES CONSULTING, INCORPORATED for revised lcats to meet government needs. Competition extent: full and open competition after exclusion of sources with 2 offers received. The procurement used a SERVICE DISABLED VETERAN OWNED SMALL BUSINESS SET-ASIDE set-aside. This award is one of several similar procurements from Department of Veterans Affairs — related awards are listed below.
Contractor Information
Similar Awards
THE PURPOSE OF THIS ACQUISITION IS TO PROVIDE THE DEPARTMENT OF VETERANS AFFAIRS WITH AN ENTERPRISE AGREEMENT FOR BRAND NAME MICROSOFT SOFTWARE PRODUCTS AND SERVICES. THIS ENTERPRISE AGREEMENT WILL PROVIDE 1) SUPPORT SERVICES 2) OPERATIONAL SUPPORT AND 3) ADDITIONAL LICENSES OF MICROSOFT PRODUCTS, CURRENT AND PLANNED, TO SUPPORT THE VA ENTERPRISE. SUBJECT PROCUREMENT WAS COMPETED AMONG MICROSOFT'S EIGHT AUTHORIZED FEDERAL GOVERNMENT LICENSE SOLUTION PROVIDERS. IGF::OT::IGF
DELL FEDERAL SYSTEMS L.P
$1.7B
THE PURPOSE OF THIS ACQUISITION IS TO PROVIDE THE DEPARTMENT OF VETERANS AFFAIRS WITH AN ENTERPRISE AGREEMENT FOR BRAND NAME MICROSOFT SOFTWARE PRODUCTS AND SERVICES. THIS ENTERPRISE AGREEMENT WILL PROVIDE 1) SUPPORT SERVICES 2) OPERATIONAL SUPPORT AND 3) ADDITIONAL LICENSES OF MICROSOFT PRODUCTS, CURRENT AND PLANNED, TO SUPPORT THE VA ENTERPRISE. SUBJECT PROCUREMENT WAS COMPETED AMONG MICROSOFT'S EIGHT AUTHORIZED FEDERAL GOVERNMENT LICENSE SOLUTION PROVIDERS. IGF::OT::IGF
DELL FEDERAL SYSTEMS L.P
$1.7B
EHRM WAVES K, L, M (VISN 23) AND N, O (VISN 15) DEPLOYMENTS
ORACLE HEALTH GOVERNMENT SERVICES, INC.
$1.7B
IGF::OT::IGF TASK ORDER 36C10B18N0003 UNDER IDIQ CONTRACT 36C10B18D5000 FOR OPERATIONAL MANAGEMENT SERVICES, TO INCLUDE HOSTING, FOR THE EHRM APPLICATIONS, APPLICATION SERVICES, AND ALL SUPPORTING EHRM DATA.
ORACLE HEALTH GOVERNMENT SERVICES, INC.
$1.5B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 NOVEMBER
MCKESSON CORPORATION
$1.4B
Stay Updated
Get notified about new opportunities matching your interests.